China Journal of Leprosy and Skin Diseases ›› 2023, Vol. 39 ›› Issue (9): 688-692.doi: 10.12144/zgmfskin202309688

• Reviews • Previous Articles     Next Articles

Neuroimmune mechanisms of IL-33 involved in type 2 inflammatory pruritus

ZHOU Lingxuan1, ZHAO Yang2, YUAN Xiaohui1, XU Zhe2,3, LIU Lingling1, WANG Yang1, ZHAO Jiahui1   

  1. 1 Department of Dermatology, Peking University First Hospital & Beijing Key Laboratory of Molecular Diagnosis on Dermatoses & National Clinical Research Center for Skin and Immune Disease & NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing 100034, China;
    2 Shunyi Maternal and Children's Hospital of Beijing Children's Hospital, Beijing 101300,China;
    3 Department of Dermatology, Beijing Children's Hospital, Capital Medical University & National Center for Children's Health, Beijing 100045,China
  • Online:2023-09-15 Published:2023-09-05

Abstract: IL-33 is a nuclear cytokine of the IL-1 family, which acts on a variety of cells through combination its receptors, such as mast cells, innate lymphocytes type 2, basophils, etc. . It is one of the important cytokines in the development and maintenance of type 2 immune responses. Recent studies have shown that IL-33 is involved in pruritic signaling through activating the peripheral nervous system. This paper focuses on the signal transduction mechanism after the activation of interleukin 33 receptor, and elaborates the neuroimmune mechanism of IL-33 involved in pruritus in type 2 inflammatory skin diseases. We also review the advances of drug research targeting IL-33.

Key words: interleukin-33, pruritus, type 2 inflammation, neuroimmunity